Treatment | Protein g/dl | MDA N mol/ml | SOD % (U/ml) | Catalase (U/ml) | Acetylcholinesterase (U/ml) |
---|---|---|---|---|---|
Normal control | 13.86 ± 0.44a | 8.34 ± 0.25e | 9.11 ± 0.27 a | 813.25 ± 3.27a | 7439.63 ± 45.31a |
Control oil treatment | 13.98 ± 0.45a | 8.00 ± 0.27e | 9.24 ± 0.29 a | 828.78 ± 2.23a | 7493.46 ± 37.71a |
Bisphenol A (BPA) | 5.82 ± 0.31g | 23.66 ± 0.60a | 2.85 ± 0.18 f | 403.90 ± 6.23g | 3512.54 ± 161.87g |
Protective low dose of FCE | 10.22v0.24cd | 12.02 ± 0.39c | 7.63 ± 0.18 bd | 684.45 ± 6.02d | 6208.54 ± 47.35d |
Protective medium dose of FCE | 10.73 ± 0.22c | 10.88 ± 0.32d | 6.94 ± 0.10 c | 713.031 ± 9.61c | 6535.61 ± 61.24c |
Protective high dose of FCE | 11.62 ± 0.22b | 10.74 ± 0.25d | 6.13 ± 0.15 d | 767.44 ± 11.11b | 6931.00 ± 84.30b |
Therapeutic low dose of FCE | 8.24 ± 0.25f | 14.50 ± 0.21b | 5.74 ± 0.11 d | 600.28 ± 3.60f | 5845.27 ± 60.21f |
Therapeutic medium dose of FCE | 9.25 ± 0.27e | 13.82 ± 0.28b | 5.17 ± 0.15 e | 615.794 ± 2.961f | 5985.03 ± 22.72ef |
Therapeutic high dose of FCE | 9.63 ± 0.19de | 12.60 ± 0.57c | 4.66 ± 0.12 e | 641.36 ± 4.55e | 6117.85 ± 2573de |